Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin
- 24 December 2004
- journal article
- case report
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 131 (5), 300-304
- https://doi.org/10.1007/s00432-004-0656-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: results of a new treatment paradigmInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Inflammation of Actinic Keratoses During Capecitabine TherapyArchives of Dermatology, 2004
- Phase I and pharmacokinetic study of the association of capecitabine–cisplatin in head and neck cancer patientsAnnals of Oncology, 2003
- The Majority of Cutaneous Squamous Cell Carcinomas Arise in Actinic KeratosesJournal of Cutaneous Medicine and Surgery, 2002
- Clinical experience of capecitabine in metastatic breast cancerEuropean Journal of Cancer, 2002
- Phase I trial of capecitabine in combination with interferon alpha in patients with metastatic renal cancer: toxicity and pharmacokineticsCancer Chemotherapy and Pharmacology, 2001
- CapecitabineDrugs, 2001
- Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues.International Journal of Oncology, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Cisplatin and 5-Fluorouracil for Metastatic Squamous Cell Carcinoma from Unknown PrimaryCancer Investigation, 1995